BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32681462)

  • 41. Acromegaly and thyroid cancer: analysis of evolution in a series of patients.
    Danilowicz K; Sosa S; Gonzalez Pernas MS; Bamberger E; Diez SM; Fainstein-Day P; Furioso A; Glerean M; Guitelman M; Katz D; Lemaitre N; Lowenstein A; Del Valle Luna M; Martínez MP; Miragaya K; Moncet D; Ortuño MV; Pignatta A; Ramacciotti CF; Reyes A; Rogozinski AS; Slavinsky P; Tkatch J; Pitoia F
    Clin Diabetes Endocrinol; 2020 Nov; 6(1):24. PubMed ID: 33292786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple primary tumors in differentiated thyroid carcinoma and relationship to thyroid cancer outcome.
    Omür O; Ozcan Z; Yazici B; Akgün A; Oral A; Ozkiliç H
    Endocr J; 2008 May; 55(2):365-72. PubMed ID: 18277003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adapted dietary inflammatory index and differentiated thyroid carcinoma risk in two French population-based case-control studies.
    Lécuyer L; Laouali N; Hajji-Louati M; Paquet M; Souchard V; Karimi M; Schvartz C; Guizard AV; Xhaard C; Rubino C; Ren Y; Borson-Chazot F; Adjadj E; Cordina-Duverger E; De Vathaire F; Guénel P; Boutron-Ruault MC; Truong T
    Eur J Nutr; 2022 Mar; 61(2):1097-1108. PubMed ID: 34718861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamic profile of differentiated thyroid cancer in male and female patients with thyroidectomy during 2000-2013 in China: a retrospective study.
    Yan HX; Pang P; Wang FL; Tian W; Luo YK; Huang W; Yang GQ; Jin N; Zang L; Du J; Ba JM; Dou JT; Mu YM; Lyu ZH
    Sci Rep; 2017 Nov; 7(1):15832. PubMed ID: 29158505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complications of acromegaly: thyroid and colon.
    Tirosh A; Shimon I
    Pituitary; 2017 Feb; 20(1):70-75. PubMed ID: 27631334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acromegaly and cancer risk: a cohort study in Sweden and Denmark.
    Baris D; Gridley G; Ron E; Weiderpass E; Mellemkjaer L; Ekbom A; Olsen JH; Baron JA; Fraumeni JF
    Cancer Causes Control; 2002 Jun; 13(5):395-400. PubMed ID: 12146843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene Expression Signature in Adipose Tissue of Acromegaly Patients.
    Hochberg I; Tran QT; Barkan AL; Saltiel AR; Chandler WF; Bridges D
    PLoS One; 2015; 10(6):e0129359. PubMed ID: 26087292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Markers of Metabolic Syndrome in Patients with Pituitary Adenoma: A Case Series of 303 Patients.
    Altuntaş SÇ; Evran M; Sert M; Tetiker T
    Horm Metab Res; 2019 Nov; 51(11):709-713. PubMed ID: 31683340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
    Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
    Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acromegaly associated with GIST, non-small cell lung carcinoma, clear cell renal carcinoma, multiple myeloma, medulla oblongata tumour, adrenal adenoma, and follicular thyroid nodules.
    Jawiarczyk-Przybyłowska A; Wojtczak B; Whitworth J; Sutkowski K; Bidlingmaier M; Korbonits M; Bolanowski M
    Endokrynol Pol; 2019; 70(2):213-217. PubMed ID: 30742299
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors.
    Kara M; Tokat F; Pamir MN; Danyeli AE
    Endocr Pathol; 2020 Jun; 31(2):166-173. PubMed ID: 32157655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-grade inflammation independently associates with cardiometabolic risk in children with overweight/obesity.
    Lund MAV; Thostrup AH; Frithioff-Bøjsøe C; Lausten-Thomsen U; Hedley PL; Pedersen O; Christiansen M; Hansen T; Holm JC
    Nutr Metab Cardiovasc Dis; 2020 Aug; 30(9):1544-1553. PubMed ID: 32571613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis.
    Ho T; Zhao C; Zheng R; Liu Z; Wei Q; Sturgis EM
    Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):756-61. PubMed ID: 16847185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiometabolic risk factors in preschool children with abdominal obesity from Medellín, Colombia.
    Marín-Echeverri C; Aristizábal JC; Gallego-Lopera N; Santa-Ramírez HA; Hoyos-Gómez M; Ruiz-Pineda AM; Arias AA; Barona-Acevedo J
    J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1179-1189. PubMed ID: 30367807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin resistance and insulin secretion in non-diabetic acromegalic patients.
    Coculescu M; Niculescu D; Lichiardopol R; Purice M
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):308-16. PubMed ID: 17516294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obesity as a risk factor for thyroid cancer.
    Matrone A; Ferrari F; Santini F; Elisei R
    Curr Opin Endocrinol Diabetes Obes; 2020 Oct; 27(5):358-363. PubMed ID: 32740043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
    Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
    Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential Impact of BMI on the Aggressiveness of Presentation and Clinical Outcome of Differentiated Thyroid Cancer.
    Matrone A; Ceccarini G; Beghini M; Ferrari F; Gambale C; D'Aqui M; Piaggi P; Torregrossa L; Molinaro E; Basolo F; Vitti P; Santini F; Elisei R
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31875910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lanreotide autogel and insulin sensitivity markers: report of 5 acromegalic patients and literature review.
    Ertorer ME; Bakiner O; Anaforoglu I; Bozkirli E; Tutuncu NB; Demirag NG
    Neuro Endocrinol Lett; 2007 Dec; 28(6):727-33. PubMed ID: 18063933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.